Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axon Enterprise Inc (AXON) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Axon Enterprise IncTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Axon Enterprise Inc vs Neurocrine Biosciences Inc — how do they compare? Axon Enterprise Inc trades at $619.45 (market cap $51.69B), while Neurocrine Biosciences Inc trades at $158.83 (market cap $16.46B). The key difference: Axon Enterprise Inc is far larger — about 3.1× Neurocrine Biosciences Inc's market cap. Which is the better fit depends on your goals.

AXONNBIX
Market Cap
$51.69B$16.46B
Sector
TechnologyHealth
52-Week High
$791.62$185.50
52-Week Low
$345.94$123.10
Enterprise Value
$52.83B$16.48B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axon Enterprise Inc

Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.

Read more on AXON

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX